Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Innere Medizin IV - Nieren- und Hochdruckkrankheiten
Leitung: Prof. Dr. Danilo Fliser
Sie befinden sich hier: >> Startseite >> Klinische Zentren und Einrichtungen >> Klinische Zentren und Einrichtungen am UKS >> Medizinische Kliniken >> Innere Medizin IV >> Forschung >> 2010

Publikationen 2010

Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH.

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.

Nephrol Dial Transplant 2010 Dec;25(12):3983-9. Impact Punkte: 3,3. Abstract


Krebs S, Omer B, Omer TN, Fliser D.

Wormwood (Artemisia absinthium) for Poorly Responsive Early-Stage IgA Nephropathy: A Pilot Uncontrolled Trial.

Am J Kidney Dis 2010 Dec;56(6):1095-9. Impact Punkte: 5,2. Abstract


Theurl M, Schgoer W, Albrecht K, Jeschke J, Egger M, Beer AG, Vasiljevic D, Rong S, Wolf AM, Bahlmann FH, Patsch JR, Wolf D, Schratzberger P, Mahata SK, Kirchmair R.

The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor-Dependent Mechanism.

Circ Res 2010 Nov 26;107(11):1326-35. Impact Punkte: 9,2. Abstract


Good DM, Zurbig P, Argiles A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neususs C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Mol Cell Proteomics 2010 Nov;9(11):2424-37. Impact Punkte: 8,8. Abstract


Weingärtner O, Pinsdorf T, Rogacev KS, Blömer L, Grenner Y, Gräber S, Ulrich C, Girndt M, Böhm M, Fliser D, Laufs U, Lütjohann D, Heine GH.

The relationships of markers of cholesterol homeostasis with carotid intima-media thickness.

PLoS One 2010; 5(10):e13467. Impact Punkte: 4,4. Abstract


Kielstein JT, Fliser D.

Do sea stars have low ADMA levels? High ADMA and low EPC count--duo infernal for the kidney.

Nephrol Dial Transplant 2010 Oct; 25(10):3138-41. Impact Punkte: 3,3. Abstract


Rifai K, Bode-Boeger SM, Martens-Lobenhoffer J, Ernst T, Kretschmer U, Hafer C, Fliser D, Manns MP, Kielstein JT.

Removal of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption.

Scand J Gastroenterol 2010 Sep;45(9):1110-5. Impact Punkte: 2,1. Abstract


Mohrbach J, Janssen MWW, Heine GH, Gärtner BC, Fliser D, Sester M, Sester U.
Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBV-infection using a pre-emptive therapy approach.
J Clin Virol 2010 Sep;49(1):53-7. Impact Punkte: 3,1. Abstract


Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sanchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A.

Recommendations for biomarker identification and qualification in clinical proteomics.

Sci Transl Med 2010 Aug 25;2(46):46ps2. Abstract


David S, Kümpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Boger SM, Kliem V, Haller H, Kielstein JT.

Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.

Nephrol Dial Transplant 2010 Aug;25(8):2571-6. Impact Punkte: 3,3. Abstract


Fliser D.

Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease.

J Nephrol 2010 Jul-Aug;23(4):369-76. Impact Punkte: 1,3. Abstract


Lorenzen J, David S, Bahlmann FH, de Groot K, Bahlmann E, Kielstein JT, Haller H, Fliser D.

Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease - a prospective follow-up study.

PLoS One 2010;5(7):e11477. Impact Punkte: 4,4. Abstract


Ulrich C, Heine GH, Seibert E, Fliser D, Girndt M.

Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.

Nephrol Dial Transplant 2010 Jul;25(7):2265-72. Impact Punkte: 3,3. Abstract


Rogacev KS, Heine GH.

Human monocyte heterogeneity-a nephrological perspective.

Nephrol Ther 2010 Jul;6(4):219-25. Impact Punkte: 0,4. Abstract


Frank H, Pscherer S, Fliser D, Heemann U.

Effect of experimental hyperglycaemia on renal haemodynamics in prediabetic patients with and without AT1 receptor blockade.

Eur J Clin Invest 2010 May;40(5):414-21. Impact Punkte: 2,6. Abstract


Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvath T, Jiang H, Sorrentino SA, Steenken N, Manes C, Marzilli M, Rudolph KL, Luscher TF, Drexler H, Landmesser U.

Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction.

Hypertension 2010 Jun;55(6):1389-97. Impact Punkte: 6,6. Abstract


Lorenzen J, Kramer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT.

Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.

Eur J Clin Invest 2010 Apr;40(4):294-300. Impact Punkte: 2,6. Abstract


Fliser D, Kleophas W, Dellana F, Winkler RE, Backs W, Kraatz U, Fassbinder W, Wizemann V, Strack G.

Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study.

Curr Med Res Opin 2010 May;26(5):1083-9. Impact Punkte: 2,5. Abstract


Gerhart MK, Seiler S, Grün OS, Rogacev KS, Fliser D, Heine GH.

Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival.
Nephrol Dial Transplant 2010 Apr;25(4):1294-300. Impact Punkte: 3,3. Abstract


Dominiczak AF, Herget-Rosenthal S, Delles C, Fliser D, Fournier I, Graber A, Girolami M, Holmes E, Lang F, Molina F, Nicholson J, Remuzzi G, Rossing P, Rudolph KL, Wolkenhauer O, Xenarios I, Zubarev R, Zubov D, Vlahou A, Schanstra JP.

Systems biology to battle vascular disease.

Nephrol Dial Transplant 2010 Apr;25(4):1019-22. Impact Punkte: 3,3. Abstract


Sester M, Giehl CSester U, Meyerhans A.

Management of tuberculosis in HIV infection: where T-cells matter.

Eur Respir J 2010 Mar;35(3):475-6. Impact Punkte: 5,5. Abstract


Lorenzen JM, Neunhoffer H, David S, Kielstein JT, Haller H, Fliser D.
Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension-Results from the EUTOPIA trial.
Atherosclerosis 2010 Mar;209(1):184-8. Impact Punkte: 4,5. Abstract 


Kümpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R.

Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome.

Intensive Care Med 2010 Mar; 36(3):462-70. Impact Punkte: 5,2. Abstract


Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, Faulhaber-Walter R, Kielstein JT.

Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.

Crit Care 2010 Feb 1;14(1):R9. Impact Punkte: 4,9. Abstract


Schlitt A, Schwaab B, Fingscheidt K, Lackner KJ, Heine GH, Vogt A, Buerke M, Maegdefessel L, Raaz U, Werdan K, Jiang XC.

Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Lipids 2010 Feb;45(2):129-35. Impact Punkte: 2,4. Abstract


Rogacev KS, Ulrich C, Blomer L, Hornof F, Oster K, Ziegelin M, Cremers B, Grenner Y, Geisel J, Schlitt A, Kohler H, Fliser D, Girndt M, Heine GH.
Monocyte heterogeneity in obesity and subclinical atherosclerosis.
Eur Heart J 2010 Feb;31(3):369-76. Impact Punkte: 9,8. Abstract


Rifai K, Das A, Rosenau J, Ernst T, Kretschmer U, Haller H, Fliser D, Manns MP.
Changes in Plasma Amino Acids During Extracorporeal Liver Support by Fractionated Plasma Separation and Adsorption.
Artif Organs 2010 Feb;34(2):166-70. Impact Punkte: 1,8. Abstract


Bahlmann FH, Speer T, Fliser D.

Endothelial progenitor cells in chronic kidney disease.

Nephrol Dial Transplant 2010 Feb;25(2):341-6. Impact Punkte: 3,3. Abstract


Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, Mueller M, Horvath T, Doerries C, Heinemann M, Flemmer S, Markowski A, Manes C, Bahr MJ, Haller H, von Eckardstein A, Drexler H, Landmesser U.
Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy.
Circulation 2010 Jan 5;121(1):110-22. Impact Punkte: 14,8. Abstract


Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K.
Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus.
Artif Organs 2010 Jan;34(1):84-8. Impact Punkte: 1,8. Abstract


Innere Medizin IV - Nieren- und Hochdruckkrankheiten

Univ.-Prof. Dr. med.
Danilo Fliser
Direktor der Klinik

Klinik für Innere Medizin IV
Kirrberger Straße 100
Gebäude 41 (IMED)
66421 Homburg (Saar)
06841 / 16-15041
06841 / 16-15042
danilo.fliser @uks.eu

Direktkontakt für niedergelassene Kolleg*innen

Niedergelassene Kolleg*innnen erreichen den diensthabenden Oberarzt der Klinik rund um die Uhr über folgende Telefonnummern:

06841 / 16 - 15 000
06841 / 16 - 15 003

Direkte Rufnummern

Vorwahl: 06841 / 16 -
Station 2, M4-KUD   
Tel. -15 300
Station 3, M4-NWS Tel. -15 300
Tel. -23 503
Peritonealdialyse Tel. -23 534
Tel. -23 503
Ambulanz / Spezialsprechstunde
Zentrales Callcenter          
Tel. -15 966
Transplantationsambulanz Tel. - 15 241
Transplantationsbüro Tel. - 15 857

Der Weg zur Klinik

Für einen Routenplaner
zum Klinikum: Klicken Sie hier!

Sie finden und auf dem
Campus in Gebäude 41
Gebäude 41